Leukemia and Lymphoma Society, Forma Therapeutics to Advance Blood Cancer Rxs to Clinic

LLS will select ten small molecule candidates deemed to have the best chance of quickly advancing to clinical trials from its portfolio of grant-funded academic research projects, and Forma will use its computational solvent mapping technology to ready the molecules for the clinic.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.